Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
H&D Wireless Sweden Holding B | HDWB | 28. mar 2024 | 0.03 | +2.65 |
H&M B | HMB | 28. mar 2024 | 174.58 | -1.78 |
HAKI Safety A | HAKIA | 28. mar 2024 | 25.40 | 0.00 |
HAKI Safety B | HAKIB | 28. mar 2024 | 25.40 | 0.00 |
Hamlet BioPharma AB (publ) | HAMLETB | 28. mar 2024 | 1.70 | -2.86 |
Hansa Biopharma | HNSA | 28. mar 2024 | 29.10 | -0.89 |
Hanza AB | HANZA | 28. mar 2024 | 66.60 | +1.83 |
Harm Reduction Group | NOHARM | 28. mar 2024 | 0.16 | +0.31 |
Havsfrun Investment | HAVS | 28. mar 2024 | 15.50 | -0.39 |
Havsfrun Investment B | HAVB | 28. mar 2024 | 15.50 | -0.39 |
Haypp Group | HAYPP | 28. mar 2024 | 84.60 | +1.93 |
Headsent | VIMAB | 28. mar 2024 | 9.80 | +1.55 |
Heba B | HEBAB | 28. mar 2024 | 34.70 | +1.31 |
Hedera Group | HEGR | 28. mar 2024 | 6.02 | +3.44 |
Heimstaden Pref | HEIMPREF | 28. mar 2024 | 9.00 | +2.86 |
Heliospectra | HELIO | 28. mar 2024 | 0.36 | 0.00 |
Hemnet Group | HEM | 28. mar 2024 | 327.80 | -0.61 |
Hemply Balance | HMPLY | 28. mar 2024 | 0.04 | -39.13 |
Hexagon B | HEXAB | 28. mar 2024 | 126.70 | -0.43 |
Hexagon Purus | HPURO | 28. mar 2024 | 5.93 | 0.00 |
Hexatronic Group | HTRO | 28. mar 2024 | 32.92 | +0.06 |
Hexicon | HEXI | 28. mar 2024 | 0.50 | 0.00 |
Hexpol B | HPOLB | 28. mar 2024 | 130.60 | -2.32 |
Hifab B | HIFAB | 28. mar 2024 | 2.50 | +1.63 |
High Coast Distillery B | HIGHCOB | 28. mar 2024 | 44.90 | +4.66 |
Hilbert | HILBB | 28. mar 2024 | 4.11 | 0.00 |
HMS Networks | HMS | 28. mar 2024 | 463.60 | +0.74 |
Hoegh Autoliners ASA | HAUTOO | 28. mar 2024 | 92.80 | 0.00 |
Hoi Publishing AB | HOIB | 28. mar 2024 | 0.41 | 0.00 |
Hoist Finance | HOFI | 28. mar 2024 | 53.10 | -0.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.